Katharina Büsch

794 total citations
20 papers, 444 citations indexed

About

Katharina Büsch is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, Katharina Büsch has authored 20 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Hepatology and 5 papers in Genetics. Recurrent topics in Katharina Büsch's work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Inflammatory Bowel Disease (4 papers). Katharina Büsch is often cited by papers focused on Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Inflammatory Bowel Disease (4 papers). Katharina Büsch collaborates with scholars based in Sweden, Germany and United States. Katharina Büsch's co-authors include Jonas F. Ludvigsson, Johan Askling, Martin Neovius, Anders Ekbom, Karin Ekström‐Smedby, Jan Kövamees, Jonas Söderholm, Nick Bansback, Amnon Sonnenberg and Nora Huang and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Katharina Büsch

20 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharina Büsch Sweden 10 256 166 101 79 77 20 444
Jami Kinnucan United States 10 356 1.4× 454 2.7× 186 1.8× 86 1.1× 47 0.6× 51 697
C N Bernstein Canada 11 229 0.9× 308 1.9× 211 2.1× 35 0.4× 39 0.5× 33 587
Eleftheria Roma‐Giannikou Greece 13 135 0.5× 134 0.8× 163 1.6× 20 0.3× 52 0.7× 22 426
Lilani P. Perera United States 11 205 0.8× 170 1.0× 161 1.6× 23 0.3× 18 0.2× 35 493
Naim Abu‐Freha Israel 12 144 0.6× 60 0.4× 78 0.8× 87 1.1× 62 0.8× 61 406
Ariela Holmer United States 8 150 0.6× 206 1.2× 71 0.7× 18 0.2× 51 0.7× 13 342
Sue Skaros United States 9 326 1.3× 269 1.6× 156 1.5× 25 0.3× 30 0.4× 10 533
Matteo Bramuzzo Italy 15 215 0.8× 314 1.9× 150 1.5× 23 0.3× 101 1.3× 83 609
Madunil Anuk Niriella Sri Lanka 14 382 1.5× 73 0.4× 128 1.3× 199 2.5× 27 0.4× 85 650
B. Papadatou Italy 15 238 0.9× 314 1.9× 228 2.3× 20 0.3× 63 0.8× 48 661

Countries citing papers authored by Katharina Büsch

Since Specialization
Citations

This map shows the geographic impact of Katharina Büsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Büsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Büsch more than expected).

Fields of papers citing papers by Katharina Büsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Büsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Büsch. The network helps show where Katharina Büsch may publish in the future.

Co-authorship network of co-authors of Katharina Büsch

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Büsch. A scholar is included among the top collaborators of Katharina Büsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Büsch. Katharina Büsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Upton, Julia, et al.. (2025). Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS). Orphanet Journal of Rare Diseases. 20(1). 212–212. 1 indexed citations
2.
Büsch, Katharina, et al.. (2024). Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review. Advances in Therapy. 42(2). 752–771. 1 indexed citations
3.
Paschke, Kerstin, Silke Diestelkamp, Antonia Zapf, et al.. (2024). An app-based training for adolescents with problematic digital-media use and their parents (Res@t digital): protocol for a cluster-randomized clinical trial. Frontiers in Psychiatry. 14. 1245536–1245536. 5 indexed citations
4.
Büsch, Katharina, Fredrik Hansson, Martin Lagging, et al.. (2020). Sick leave and disability pension in patients with chronic hepatitis C compared with a matched general population: a nationwide register study. BMJ Open. 10(9). e035996–e035996. 2 indexed citations
5.
Kåberg, Martin, Simon B. Larsson, Anna Jerkeman, et al.. (2020). High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder. Scandinavian Journal of Gastroenterology. 55(5). 574–580. 1 indexed citations
6.
Aleman, Soo, Jonas Söderholm, Katharina Büsch, Jan Kövamees, & Ann‐Sofi Duberg. (2020). Frequent loss to follow‐up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virus. Liver International. 40(8). 1832–1840. 26 indexed citations
7.
Kny, Melanie, Katharina Büsch, Elke Dworatzek, et al.. (2019). Ninjurin1 regulates striated muscle growth and differentiation. PLoS ONE. 14(5). e0216987–e0216987. 7 indexed citations
8.
Söderholm, Jonas, Aylin Yilmaz, Anders Svenningsson, et al.. (2019). Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study. Journal of Neurology. 266(9). 2208–2215. 2 indexed citations
9.
Ludvigsson, Johnny, Katharina Büsch, Ola Olén, et al.. (2017). Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study. BMC Gastroenterology. 17(1). 23–23. 32 indexed citations
10.
Söderholm, Jonas, Katharina Büsch, Jan Kövamees, et al.. (2017). Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis. Journal of Hepatology. 68(5). 904–911. 33 indexed citations
11.
Huang, Nora, Melanie Kny, Fabian Riediger, et al.. (2017). Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy. Intensive Care Medicine Experimental. 5(1). 3–3. 78 indexed citations
12.
13.
Büsch, Katharina, J. Waldenström, Martin Lagging, et al.. (2016). Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden. Scandinavian Journal of Gastroenterology. 52(1). 61–68. 13 indexed citations
14.
Büsch, Katharina, Jan Kövamees, & Jonas Söderholm. (2015). Prevalence of Hepatitis C And Presence of Comorbidities In Sweden: A Nationwide Population-Based Register Study. Value in Health. 18(7). A575–A576. 1 indexed citations
15.
Büsch, Katharina, Amnon Sonnenberg, & Nick Bansback. (2014). Impact of Inflammatory Bowel Disease on Disability. Current Gastroenterology Reports. 16(10). 414–414. 33 indexed citations
16.
Büsch, Katharina, et al.. (2014). Sick leave and disability pension in inflammatory bowel disease: A systematic review. Journal of Crohn s and Colitis. 8(11). 1362–1377. 43 indexed citations
17.
Bentley, Anthony, et al.. (2013). A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom. Health Economics Review. 3(1). 18–18. 32 indexed citations
18.
Büsch, Katharina, Jonas F. Ludvigsson, Karin Ekström‐Smedby, et al.. (2013). Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Alimentary Pharmacology & Therapeutics. 39(1). 57–68. 112 indexed citations
19.
King, Vera & Katharina Büsch. (2012). Widersprüchliche Zeiten des Aufwachsens - Fürsorge, Zeitnot und Optimierungsstreben in Familien. Social Science Open Access Repository (GESIS – Leibniz Institute for the Social Sciences). 7(1). 7–23. 3 indexed citations
20.
Hillemanns, Peter, et al.. (2008). Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany. Journal of Public Health. 17(2). 77–86. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jami Kinnucan Breakdown of academic impact, for papers by C N Bernstein Breakdown of academic impact, for papers by Eleftheria Roma‐Giannikou Breakdown of academic impact, for papers by Lilani P. Perera Breakdown of academic impact, for papers by Naim Abu‐Freha Breakdown of academic impact, for papers by Ariela Holmer Breakdown of academic impact, for papers by Sue Skaros Breakdown of academic impact, for papers by Matteo Bramuzzo Breakdown of academic impact, for papers by Madunil Anuk Niriella Breakdown of academic impact, for papers by B. Papadatou
Rankless by CCL
2026